Cargando…

Trastuzumab-induced cardiotoxicity in early breast cancer over a 10-year period in Uruguay

This srudy aimed to estimate the prevalence of trastuzumab-induced cardiotoxicity in Uruguayan women diagnosed with human epidermal growth factor receptor 2 (HER2)-positive breast cancer over a 10-year period, who were treated under the financial coverage of the National Resources Fund (Fondo Nacion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castillo, Cecilia, Camejo, Natalia, Etcheverria, Cristian, Ferradaz, Jessica, Ferreira, Agustin, Fontan, Analia, Gabin, Ana Sofia, Herrera, Guadalupe, Artagaveytia, Nora, Parma, Gabriel, Delgado, Lucía
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333491/ https://www.ncbi.nlm.nih.gov/pubmed/35905268 http://dx.doi.org/10.1097/MD.0000000000029927

Ejemplares similares

Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
por: Castillo, Cecilia, et al.
Publicado: (2021)

Zoonotic Potential and Antibiotic Resistance of Escherichia coli in Neonatal Calves in Uruguay
por: Umpiérrez, Ana, et al.
Publicado: (2017)

Prevalence of Known Risk Factors in Uruguayan Women Treated for Breast Cancer at a University Hospital
por: Castillo, Cecilia, et al.
Publicado: (2021)

Inclusion of information technology-based assessments of health-related quality of life in routine oncology practice in Uruguay
por: Castillo, Cecilia, et al.
Publicado: (2022)

Trastuzumab Cardiotoxicity in Patients with Breast Cancer
por: Freitas, Aguinaldo Figueiredo, et al.
Publicado: (2014)

Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
por: Castillo, Cecilia, et al.
Publicado: (2022)

Breast cancer risk and genetic ancestry: a case–control study in Uruguay
por: Bonilla, Carolina, et al.
Publicado: (2015)

169P Evaluation of the effectiveness of telephone consultations and the level of satisfaction of patients attending the Unidad Docente Asistencial de Mastología [Mastology Care Teaching Unit] using this method during the COVID health emergency
por: Camejo, N., et al.
Publicado: (2021)

Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
por: Marinko, Tanja, et al.
Publicado: (2014)

Effectiveness of Trastuzumab for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Real-Life Setting: One Decade of Experience Under National Treatment Coverage Regulations
por: Camejo, Natalia, et al.
Publicado: (2020)

Shiga toxin-producing Escherichia coli in human, cattle, and foods. Strategies for detection and control
por: Padola, Nora L., et al.
Publicado: (2014)

Shiga toxin-producing Escherichia coli: Factors involved in virulence and cattle colonization
por: Etcheverría, Analía Inés, et al.
Publicado: (2013)

A Case of Trastuzumab-Associated Cardiomyopathy Presenting as an Acute Coronary Syndrome: Acute Trastuzumab Cardiotoxicity
por: Hidalgo, Sylvana, et al.
Publicado: (2013)

National stroke management plan in Uruguay: Challenges and opportunities
por: Amorín, Ignacio, et al.
Publicado: (2023)

Detection of Subclinical Trastuzumab-Induced Cardiotoxicity in Patients with Breast Cancer
por: dos Santos, Marília Harumi Higuchi
Publicado: (2013)

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)

Doxorubicin‐induced and trastuzumab‐induced cardiotoxicity in mice is not prevented by metoprolol
por: Nicol, Martin, et al.
Publicado: (2021)

Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats
por: Liu, Guang, et al.
Publicado: (2022)

Trastuzumab-related cardiotoxicity: what do we know in 2020?
por: Liu, Jia, et al.
Publicado: (2020)

Risks of trastuzumab‐related cardiotoxicity in breast cancer patients in Taiwan
por: Chang, Wei‐Ting, et al.
Publicado: (2021)

Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
por: Méndez-Valdés, Gabriel, et al.
Publicado: (2023)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
por: Eaton, Holden, et al.
Publicado: (2023)

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab
por: Zhou, Shijie, et al.
Publicado: (2023)

Relevance of Biofilms in the Pathogenesis of Shiga-Toxin-Producing Escherichia coli Infection
por: Angel Villegas, Natalia, et al.
Publicado: (2013)

Fatal Human Case of Western Equine Encephalitis, Uruguay
por: Delfraro, Adriana, et al.
Publicado: (2011)

Reinserción laboral posterior a diagnóstico y tratamiento del cáncer de mama
por: Camejo-Martínez, Natalia, et al.
Publicado: (2022)

Whole exome sequencing to identify genetic markers for trastuzumab‐induced cardiotoxicity
por: Udagawa, Chihiro, et al.
Publicado: (2018)

Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity
por: Jiang, Jiangsong, et al.
Publicado: (2017)

Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy
por: Gabani, Mohanad, et al.
Publicado: (2021)

Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience
por: Acibuca, Aynur, et al.
Publicado: (2021)

Coq10 for preventing cardiotoxicity in breast cancer patients treated with trastuzumab
por: Al-Hammadi, Nawal, et al.
Publicado: (2023)

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
por: Shrivastva, Sarita, et al.
Publicado: (2023)

Uruguay hoy
Publicado: (1971)

Uruguay : una historia breve /
por: Dutrénit, Silvia
Publicado: (1994)

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials
por: Eiger, Daniel, et al.
Publicado: (2020)

Rickettsia parkeri in Amblyomma triste from Uruguay
por: Venzal, José M., et al.
Publicado: (2004)

How can clinical research help our understanding of trastuzumab-related cardiotoxicity?
por: Lyons, Tomás G., et al.
Publicado: (2015)

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
por: Akolkar, Gauri, et al.
Publicado: (2015)

Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis
por: Jawa, Zeeshan, et al.
Publicado: (2016)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
por: Sayan, Mutlay, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_977dpavrl6prrq3r1u1rgm4hr7